Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population

BACKGROUND: Antivascular endothelial growth factor tyrosine kinase inhibitors have been used recently in the treatment of advanced differentiated thyroid cancer (DTC) and medullary thyroid cancer (MTC). Off-label sorafenib is used in Turkey with special permission by the Ministry of Health for this...

Descripción completa

Detalles Bibliográficos
Autores principales: Benekli, Mustafa, Yalcin, Suayib, Ozkan, Metin, Elkiran, Emin Tamer, Sevinc, Alper, Cabuk, Devrim, Coskun, Hasan Senol, Oksuzoglu, Berna, Bayar, Banu, Akbulat, Akif, Ozet, Ahmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271783/
https://www.ncbi.nlm.nih.gov/pubmed/25548522
http://dx.doi.org/10.2147/OTT.S70670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271783/
https://www.ncbi.nlm.nih.gov/pubmed/25548522
http://dx.doi.org/10.2147/OTT.S70670

Ejemplares similares